Skip to main content

ACAD

ACADIA PHARMACEUTICALS INC
ShareXLinkedInReddit
Sector
Biotechnology
Last price
$26.22
As of

Active signals for ACAD

Top institutional holders of ACAD (13F)

FundMarket value% portfolioQoQ
Point72 Asset Management, L.P.$90.2M0.10%+127.2%
RENAISSANCE TECHNOLOGIES LLC$40.9M0.06%+5.7%
RENAISSANCE TECHNOLOGIES LLC$38.4M0.06%+12.5%
Point72 Asset Management, L.P.$31.7M0.05%,
MILLENNIUM MANAGEMENT LLC$31.7M0.01%,
RENAISSANCE TECHNOLOGIES LLC$30.9M0.04%,
TWO SIGMA INVESTMENTS, LP$29.9M0.04%+68.1%
D. E. Shaw & Co., Inc.$27.4M0.01%-14.8%
D. E. Shaw & Co., Inc.$25.7M0.01%,
TWO SIGMA INVESTMENTS, LP$17.3M0.01%-30.7%
D. E. Shaw & Co., Inc.$16.2M0.01%-28.9%
MILLENNIUM MANAGEMENT LLC$15.7M0.01%+27.4%
MILLENNIUM MANAGEMENT LLC$14.8M0.01%-62.7%
TWO SIGMA INVESTMENTS, LP$14.2M0.02%,
Bridgewater Associates, LP$3.7M0.01%-15.4%
Bridgewater Associates, LP$3.5M0.01%,
Bridgewater Associates, LP$3.2M0.01%+2.6%
CITADEL ADVISORS LLC$2M0.00%,
CITADEL ADVISORS LLC$694K0.00%-72.2%
Point72 Asset Management, L.P.$305K0.00%-99.6%

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, ACAD

Related tickers

See more ACAD signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track ACAD in your watchlist and get notified the moment a new signal fires.

Track ACAD on Kresmion →